Table 3.
Adjusted associated between PCP perceptions/characteristics and CRC screening
| Any vs. No CRC Screening (N = 95 PCPs; 6,245 Patients) | Screening by CTC vs. Other Modalities* (N = 84 PCPs; 1,906 Patients) | |||||
|---|---|---|---|---|---|---|
| PCP Perceptions and Characteristics | Odds Ratio | 95% CI | p-value | Odds Ratio | 95% CI | p-value |
| Effectiveness of CTC | 0.42 | 0.02 | ||||
| Not at all, Slightly, or Moderately | (ref) | (ref) | ||||
| Very | 1.10 | (0.86, 1.41) | 1.34 | (0.55, 3.26) | ||
| Extremely | 0.94 | (0.72, 1.23) | 2.86 | (1.13, 7.25) | ||
| Don’t Know | 1.01 | (0.67, 1.52) | 0.66 | (0.12, 3.74) | ||
| Perceived Organizational Capacity for Colonoscopy | 0.03 | 0.39 | ||||
| Just about right or More than enough | (ref) | -- | (ref) | -- | ||
| Inadequate | 1.23 | (1.02, 1.48) | 1.59 | (0.8, 3.17) | ||
| Don’t Know | 0.68 | (0.32, 1.42) | 2.38 | (0.19, 29.8) | ||
| Advantages to CTC Compared to Colonoscopy | 0.89 | 0.01 | ||||
| None | (ref) | -- | (ref) | -- | ||
| 1–3 advantages | 1.05 | (0.79, 1.39) | 1.85 | (0.57, 6.04) | ||
| 4–5 advantages | 1.01 | (0.76, 1.34) | 3.79 | (1.2, 11.97) | ||
| Age (years) | 0.72 | 0.88 | ||||
| < 40 | (ref) | -- | (ref) | -- | ||
| 41–59 | 1.01 | (0.84, 1.22) | 0.92 | (0.49, 1.75) | ||
| > 59 | 0.92 | (0.7, 1.21) | 1.12 | (0.44, 2.83) | ||
| Gender | 0.47 | 0.54 | ||||
| Male | (ref) | -- | (ref) | -- | ||
| Female | 0.94 | (0.78, 1.12) | 0.82 | (0.44, 1.53) | ||
| Specialty | < 0.01 | < 0.01 | ||||
| Family Medicine | (ref) | -- | (ref) | -- | ||
| Internal Medicine/Geriatrics | 1.41 | (1.16, 1.71) | 2.66 | (1.41, 5.03) | ||
| Clinic Management | 0.51 | 0.10 | ||||
| Hospital-owned | (ref) | -- | (ref) | -- | ||
| Physician-owned | 1.08 | (0.87, 1.34) | 1.79 | (0.9, 3.53) | ||
CRC=Colorectal Cancer, PCP=Primary Care Provider, CI=Confidence Interval
*
Other modalities include fecal occult blood testing, flexible sigmoidoscopy, double contrast barium enema, and colonoscopy